Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support - S&P Global Ratings’ Credit Research

Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support

Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support - S&P Global Ratings’ Credit Research
Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support
Published Sep 29, 2025
10 pages (5333 words) — Published Sep 29, 2025
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

S&P Global Ratings raised its long-term rating on the Oklahoma Development Finance Authority 's series 2018B tax-exempt fixed-rate bonds and series 2018C taxable fixed-rate bonds to ?BB+? from ?BB?. The bonds were issued for OU Medicine Inc. (OUMI), now doing business as OU Health. In addition, we raised our underlying rating (SPUR) on the insured maturities of the authority's series 2018B and 2018C bonds, also issued for OUMI, to ?BB+? from ?BB?. The outlook is stable. The upgrade reflects OU Health's improved and stabilized operating performance, which we anticipate will continue to support incremental growth of year-end unrestricted reserves, and sustained moderation of debt metrics. The higher rating further incorporates OU Health's leading, and growing, position within Oklahoma's health care

  
Brief Excerpt:

...S&P Global Ratings raised its long-term rating on the Oklahoma Development Finance Authority's series 2018B tax-exempt fixed-rate bonds and series 2018C taxable fixed-rate bonds to `##+' from `##'. The bonds were issued for OU Medicine Inc. (OUMI), now doing business as OU Health....

  
Report Type:

Research Update

Issuer
Sector
Global Issuers, Public Finance, Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support" Sep 29, 2025. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-OU-Medicine-Inc-OK-Debt-Rating-Raised-To-BB-On-Improved-Operating-Performance-Strong-Capital-Support-3450088>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: OU Medicine Inc., OK Debt Rating Raised To ?BB+? On Improved Operating Performance, Strong Capital Support Sep 29, 2025. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-OU-Medicine-Inc-OK-Debt-Rating-Raised-To-BB-On-Improved-Operating-Performance-Strong-Capital-Support-3450088>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.